I gave an interview about an important patent litigation that the Danish pharmaceutical company Novo Nordisk is involved in and evaluated the legal situation.


Abstract:
Kovending. Novo Nordisk har kurs mod en overrumplende sejr i et langstrakt patentslagsmål i USA. I første omgang blev Novo bortdømt af en dommer fra den amerikanske handelskommission. Samme dommer konkluderer nu i en ny redegørelse, at sagen mod Novo bør droppes | http://www.business.dk/medico/novo-styrer-mod-overraskende-sejr-i-patentkrig

I gave an interview about an important patent litigation that the Danish pharmaceutical company Novo Nordisk is involved in and evaluated the legal situation.